EUCRATES BIOMEDICAL ACQU COR - SHS (EUCR)

CUSIP: G3141W106

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / SHS
Total 13F shares
4,195,714
Share change
+3,144,727
Total reported value
$41,762,000
Price per share
$9.98
Number of holders
20
Value change
+$31,308,990
Number of buys
15
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP G3141W106?
CUSIP G3141W106 identifies EUCR - EUCRATES BIOMEDICAL ACQU COR - SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EUCRATES BIOMEDICAL ACQU COR - SHS (EUCR) as of Q1 2021

As of 31 Mar 2021, EUCRATES BIOMEDICAL ACQU COR - SHS (EUCR) was held by 20 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,195,714 shares. The largest 10 holders included BlackRock Inc., 683 Capital Management, LLC, Shay Capital LLC, Hudson Bay Capital Management LP, CVI Holdings, LLC, SPHERA FUNDS MANAGEMENT LTD., EcoR1 Capital, LLC, Granite Point Capital Management, L.P., Centiva Capital, LP, and Radcliffe Capital Management, L.P.. This page lists 20 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.